As our summary of results from a high number of patients and controls suggests that allelic variants from both DQB1 and DRB1 are equally involved in MS susceptibility/protection transethnically, it seems to be useful to type both DRB1 and HLA-DQ alleles in MS patients. This evidence concerns the gene HLA-DRB1 and myeloid sarcoma.